A. Bufe
Helios Klinikum Krefeld - Heartcenter
Dep. of Cardiology and Intensive Care
Ischemia and Viability –
How to select the right patient
A.Bufe - EuroCTO Club 2020 Berlin
I DO NOT have a financial interest/arrangement or
affiliation with one or more organizations that could
be perceived as a real or apparent conflict of
interest in the context of the subject of this
presentation
Disclosure Statement of Financial Interest
Why should we
recanalize
a CTO ?
A.Bufe - EuroCTO Club 2020 Berlin
CTO-Patients are
often severely
symptomatic
(exertional dyspnoe,
angina pectoris,
physical impairment)
A.Bufe - EuroCTO Club 2020 Berlin
CTO-Patients often have
a poor
prognosis
A.Bufe - EuroCTO Club 2020 Berlin
A.Bufe - EuroCTO Club 2020 Berlin
A.Bufe - EuroCTO Club 2020 Berlin
1 vessel disease
Patient is severely
symptomatic, AP CCS III
Normal LV-function
Do we really need
ischaemia test?
n = 1000
Success rate
86%
A.Bufe - EuroCTO Club 2020 Berlin
Sapontis et al., JACC Cariovasc Intv 2017
EURO-CTO Study
Success Failure
Decision as per usual
clinical care
Medical Rx CABG
Ongoing angina
despite OMT*
Clinically
indicated
interim PCI
Repeat Exercice Tolerance Test (ETT) for objective assessment of ischaemia @ 12m and 36months
Single-vessel disease CTO only
Multivessel CAD including CTO
Treat non-occlusive disease by
PCI before CTO with DES
Angina or
angina-
equivalent
symptoms
Randomisation 2:1
PCI with DES
+ OMT
n=800
2
OMT to include:
- Aspirin,
- Statin,
- ACE-inhibitor where tolerated
- + up to 2 anti-anginal agents at
max tolerated dose including rate-
limiting agent where appropriate.
Ischaemic symptoms should be
confirmed with non-invasive test.
OMT
n=400
1
A.Bufe - EuroCTO Club 2020 Berlin
Efficacy: Quality of Life @ 12 and 36 months
Safety: Death, non-fatal myocardial infarction (ITT, PP) @ 36 months
A.Bufe - EuroCTO Club 2020 Berlin
Werner et al., EHJ 2018
A.Bufe - EuroCTO Club 2020 Berlin
A.Bufe - EuroCTO Club 2020 Berlin
Bangalore et al., Circulation 2020; 142:841-857
A.Bufe - EuroCTO Club 2020 Berlin
Werner et al., TCT 2019
A.Bufe - EuroCTO Club 2020 Berlin
Werner et al., TCT 2019
A.Bufe - EuroCTO Club 2020 Berlin
A.Bufe - EuroCTO Club 2020 Berlin
Lee et al, Decision CTO Study, Circulation 2019;139:1674-1683
A.Bufe - EuroCTO Club 2020 Berlin
A.Bufe - EuroCTO Club 2020 Berlin
n = 19088
Multicenter registry
- propensity score
- mulivariable analysis
Azadani et al., JACC Cardiovac Img 2020
SPECT MPI
A.Bufe - EuroCTO Club 2020 Berlin
ESC Guidelines 2018
A.Bufe - EuroCTO Club 2020 Berlin
CTO LCX
1 vessel disease
No
symtoms
A.Bufe - EuroCTO Club 2020 Berlin
Rest
30yg
20yg
40yg
Dobutamin Stress-MRI
A.Bufe - EuroCTO Club 2020 Berlin
6.389 patients
Revascularization was associated
with a protective effect only in the
subset of extensive CMR-related
ischaemia
Extensive ischaemic burden was
related to a higher risc of long term
mortality
516/516
matched
patients
A.Bufe - EuroCTO Club 2020 Berlin
LAD-Stenoses
RCA-CTO
RCA distal
NSTEMI anterior wall
Hypokinesia anterior and severe Hypokinesia inferior (EF 38%)
Claessen et al., EHJ 2012;33:768-775
A.Bufe - EuroCTO Club 2020 Berlin
A.Bufe - EuroCTO Club 2020 Berlin
epicardial
collaterals
Stents
septal
collaterals
A.Bufe - EuroCTO Club 2020 Berlin
reverse CART
Subendocardial
Scar inferior
MRI for
viability
A.Bufe - EuroCTO Club 2020 Berlin
Complete
Revascularization
in
viable myocardium
A.Bufe - EuroCTO Club 2020 Berlin
Metha et al., NEJM 2019; 381:1411-1421
A.Bufe - EuroCTO Club 2020 Berlin
A.Bufe - EuroCTO Club 2020 Berlin
Galassi, Mashajekhi et al., J Am Coll Cardiol Intv 2017
n = 839
PCI of CTO in patients with low EF
A.Bufe - EuroCTO Club 2020 Berlin
n = 72
Galassi, Mashajekhi et al., J Am Coll Cardiol Intv 2017
PCI of CTO in patients with low EF
A.Bufe - EuroCTO Club 2020 Berlin
Conclusion
Galassi et al., EuroCTO Club consensus document, Eurointervention 2019
A.Bufe - EuroCTO Club 2020 Berlin
Thank you
A.Bufe - EuroCTO Club 2020 Berlin
Thank you

More Related Content

PPTX
CTO in Japan / Asia Pacific
PPTX
CTO in MVD
PPTX
CTO at the crux cordis – Which strategy?
PPTX
The EuroCTO Club after COVID-19
PPTX
CTO training
PPTX
Introduction and Welcome to participants
PPTX
ACS and CTO – how to manage
PPTX
Cortese B - AIMRADIAL 2014 - Acute kidney injury
CTO in Japan / Asia Pacific
CTO in MVD
CTO at the crux cordis – Which strategy?
The EuroCTO Club after COVID-19
CTO training
Introduction and Welcome to participants
ACS and CTO – how to manage
Cortese B - AIMRADIAL 2014 - Acute kidney injury

What's hot (20)

PPT
Spaulding C - AIMRADIAL 2013 - Heparin and radial
PPTX
Gabric ID - AIMRADIAL 2014 - Primary PCI and left radial approach
PPTX
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
PPTX
PDF
Friday 1653 – karmpalotis – stent patency post cto pci
PPTX
17:05 Goicolea - Changes after CTO Recanilization
PPTX
Euro CTO Club – The Euro CTO trial
PDF
Rao SV - AIMRADIAL 2013 - Bivalirudin and radial
PDF
Comparison of septal strain patterns in dyssynchronous heart failure between ...
PPTX
CRTP ou CRTD? Quels arguments pour notre choix? (Pr C. Leclercq)
PPTX
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
PPTX
Ruzsa Z - AIMRADIAL 2013 - Carotid artery stenting
PPT
Scalone G - AIMRADIAL 2015 - Radial in heart transplant patients
PDF
Novedades en farmacología en intervencionismo
PPTX
Munoz Mendoza J - AIMRADIAL 2015 - Radial artery vasomotion
PPT
Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013
PPTX
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMI
PPTX
Cortese B - AIMRADIAL 2014 Endovascular - Iliac intervention
Spaulding C - AIMRADIAL 2013 - Heparin and radial
Gabric ID - AIMRADIAL 2014 - Primary PCI and left radial approach
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
Friday 1653 – karmpalotis – stent patency post cto pci
17:05 Goicolea - Changes after CTO Recanilization
Euro CTO Club – The Euro CTO trial
Rao SV - AIMRADIAL 2013 - Bivalirudin and radial
Comparison of septal strain patterns in dyssynchronous heart failure between ...
CRTP ou CRTD? Quels arguments pour notre choix? (Pr C. Leclercq)
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
Ruzsa Z - AIMRADIAL 2013 - Carotid artery stenting
Scalone G - AIMRADIAL 2015 - Radial in heart transplant patients
Novedades en farmacología en intervencionismo
Munoz Mendoza J - AIMRADIAL 2015 - Radial artery vasomotion
Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMI
Cortese B - AIMRADIAL 2014 Endovascular - Iliac intervention
Ad

Similar to A.Bufe - Session1 - Ischemia and Viability - How to select the right patient (20)

PPTX
CTO and low ejection fraction
PPTX
CTO and LV assist devices
PPTX
Recent publications, key points from this year
PPTX
Ischaemic burden and changes in absolute myocardial perfusion after chronic t...
PPT
What future trials do we need in CTOs?
PPTX
CTO recanalization: when, why, how?
PDF
Alfredo R. Galassi - How to deal with very LVEF: the last remaining option to...
PPTX
10:50 Werner - Identifying the patients that benefit from CTO PCI
PPT
Acute Coronary Syndromes
PDF
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
PPTX
Long-term outcome for patients with CTOs
PPTX
EuroCTO trial Update, Comments, review of the study
PDF
Leszek Bryniarski: Mechanical protection in CTO PCI: the Krakow experience
PDF
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
PPTX
Ischemia and viability – How to select the right patient
PPT
Chronic total occlusion
PPTX
Alexander Bufe: LIAB Antegrade CTO with Bifurcation
PDF
15th Experts Live CTO: Opening Session - Emanuele Barbato
PPTX
Journal club CTO.pptx
PDF
CTO in India
CTO and low ejection fraction
CTO and LV assist devices
Recent publications, key points from this year
Ischaemic burden and changes in absolute myocardial perfusion after chronic t...
What future trials do we need in CTOs?
CTO recanalization: when, why, how?
Alfredo R. Galassi - How to deal with very LVEF: the last remaining option to...
10:50 Werner - Identifying the patients that benefit from CTO PCI
Acute Coronary Syndromes
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Long-term outcome for patients with CTOs
EuroCTO trial Update, Comments, review of the study
Leszek Bryniarski: Mechanical protection in CTO PCI: the Krakow experience
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
Ischemia and viability – How to select the right patient
Chronic total occlusion
Alexander Bufe: LIAB Antegrade CTO with Bifurcation
15th Experts Live CTO: Opening Session - Emanuele Barbato
Journal club CTO.pptx
CTO in India
Ad

More from Euro CTO Club (20)

PDF
Agostoni - 2024 EuroCTO 2024 - post CABG.pdf
PDF
Contra Flash Debate: To coil or not coil the graft in post-CABG
PDF
Flash Debate: To coil or not coil the graft in post-CABG
PDF
How did the HydroDynamic Contrast Recanalization technique changed my antegra...
PDF
Coronary calcium patterns detected with Computed Tomography and their impact ...
PDF
The Prognostic Benefit of CTO-PCI and the Complexity of Coronary Artery Disease
PDF
The relationship between serum groth differentiation factor 15 levels and cor...
PDF
Prospective Evaluation of Treatment Strategies in Patients Presenting with Ch...
PDF
Flash Highlights: Coils embolization M. Egred, UK
PDF
2024_Euro CTO Istanbul_Vadala_Final_200924.pdf
PDF
Session X: “Ongoing CTO Trials” CHIP IVUS R. Diletti, Netherlands
PDF
Session X: “Ongoing CTO Trials” DCB vs. DES in CTO A. Nap, Netherlands
PDF
16th Experts Live CTO: LIVE CASE 17 – From Medical Park Florya Hospital
PDF
16th Experts Live CTO: Ischemia CTO Trial (E. N. Holck)
PDF
16th Experts "Live" CTO: Orbita CTO Trial (J. Davies)
PDF
M. Behnes - The Ultimative Trial of CTO Revascularisation
PDF
F. Cuculi - Enhancing CTO outcomes with Drug-Coated Balloons” | supported by ...
PDF
C. di Mario - DCB Usage in the Euro CTO Club
PDF
J. Guiterrez Chico - Flash Highlight: Cost effectiveness of CTO PCI
PPTX
Flash Highlight: 3 years outcome of Euro CTO G. Werner, Germany
Agostoni - 2024 EuroCTO 2024 - post CABG.pdf
Contra Flash Debate: To coil or not coil the graft in post-CABG
Flash Debate: To coil or not coil the graft in post-CABG
How did the HydroDynamic Contrast Recanalization technique changed my antegra...
Coronary calcium patterns detected with Computed Tomography and their impact ...
The Prognostic Benefit of CTO-PCI and the Complexity of Coronary Artery Disease
The relationship between serum groth differentiation factor 15 levels and cor...
Prospective Evaluation of Treatment Strategies in Patients Presenting with Ch...
Flash Highlights: Coils embolization M. Egred, UK
2024_Euro CTO Istanbul_Vadala_Final_200924.pdf
Session X: “Ongoing CTO Trials” CHIP IVUS R. Diletti, Netherlands
Session X: “Ongoing CTO Trials” DCB vs. DES in CTO A. Nap, Netherlands
16th Experts Live CTO: LIVE CASE 17 – From Medical Park Florya Hospital
16th Experts Live CTO: Ischemia CTO Trial (E. N. Holck)
16th Experts "Live" CTO: Orbita CTO Trial (J. Davies)
M. Behnes - The Ultimative Trial of CTO Revascularisation
F. Cuculi - Enhancing CTO outcomes with Drug-Coated Balloons” | supported by ...
C. di Mario - DCB Usage in the Euro CTO Club
J. Guiterrez Chico - Flash Highlight: Cost effectiveness of CTO PCI
Flash Highlight: 3 years outcome of Euro CTO G. Werner, Germany

Recently uploaded (20)

PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPTX
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
PDF
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
PPT
Blood and blood products and their uses .ppt
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PDF
AGE(Acute Gastroenteritis)pdf. Specific.
PPTX
Approach to chest pain, SOB, palpitation and prolonged fever
PDF
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PDF
Forensic Psychology and Its Impact on the Legal System.pdf
PPTX
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
PPTX
ROJoson PEP Talk: What / Who is a General Surgeon in the Philippines?
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PPTX
Physiology of Thyroid Hormones.pptx
PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PPTX
preoerative assessment in anesthesia and critical care medicine
PPTX
Post Op complications in general surgery
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
SHOCK- lectures on types of shock ,and complications w
PPTX
Impression Materials in dental materials.pptx
nephrology MRCP - Member of Royal College of Physicians ppt
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
Blood and blood products and their uses .ppt
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
AGE(Acute Gastroenteritis)pdf. Specific.
Approach to chest pain, SOB, palpitation and prolonged fever
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
OSCE Series Set 1 ( Questions & Answers ).pdf
Forensic Psychology and Its Impact on the Legal System.pdf
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
ROJoson PEP Talk: What / Who is a General Surgeon in the Philippines?
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
Physiology of Thyroid Hormones.pptx
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
preoerative assessment in anesthesia and critical care medicine
Post Op complications in general surgery
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
SHOCK- lectures on types of shock ,and complications w
Impression Materials in dental materials.pptx

A.Bufe - Session1 - Ischemia and Viability - How to select the right patient

  • 1. A. Bufe Helios Klinikum Krefeld - Heartcenter Dep. of Cardiology and Intensive Care Ischemia and Viability – How to select the right patient
  • 2. A.Bufe - EuroCTO Club 2020 Berlin I DO NOT have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation Disclosure Statement of Financial Interest
  • 3. Why should we recanalize a CTO ? A.Bufe - EuroCTO Club 2020 Berlin
  • 4. CTO-Patients are often severely symptomatic (exertional dyspnoe, angina pectoris, physical impairment) A.Bufe - EuroCTO Club 2020 Berlin
  • 5. CTO-Patients often have a poor prognosis A.Bufe - EuroCTO Club 2020 Berlin
  • 6. A.Bufe - EuroCTO Club 2020 Berlin
  • 7. A.Bufe - EuroCTO Club 2020 Berlin 1 vessel disease Patient is severely symptomatic, AP CCS III Normal LV-function Do we really need ischaemia test?
  • 8. n = 1000 Success rate 86% A.Bufe - EuroCTO Club 2020 Berlin Sapontis et al., JACC Cariovasc Intv 2017
  • 9. EURO-CTO Study Success Failure Decision as per usual clinical care Medical Rx CABG Ongoing angina despite OMT* Clinically indicated interim PCI Repeat Exercice Tolerance Test (ETT) for objective assessment of ischaemia @ 12m and 36months Single-vessel disease CTO only Multivessel CAD including CTO Treat non-occlusive disease by PCI before CTO with DES Angina or angina- equivalent symptoms Randomisation 2:1 PCI with DES + OMT n=800 2 OMT to include: - Aspirin, - Statin, - ACE-inhibitor where tolerated - + up to 2 anti-anginal agents at max tolerated dose including rate- limiting agent where appropriate. Ischaemic symptoms should be confirmed with non-invasive test. OMT n=400 1 A.Bufe - EuroCTO Club 2020 Berlin Efficacy: Quality of Life @ 12 and 36 months Safety: Death, non-fatal myocardial infarction (ITT, PP) @ 36 months
  • 10. A.Bufe - EuroCTO Club 2020 Berlin Werner et al., EHJ 2018
  • 11. A.Bufe - EuroCTO Club 2020 Berlin
  • 12. A.Bufe - EuroCTO Club 2020 Berlin Bangalore et al., Circulation 2020; 142:841-857
  • 13. A.Bufe - EuroCTO Club 2020 Berlin
  • 14. Werner et al., TCT 2019 A.Bufe - EuroCTO Club 2020 Berlin
  • 15. Werner et al., TCT 2019 A.Bufe - EuroCTO Club 2020 Berlin
  • 16. A.Bufe - EuroCTO Club 2020 Berlin Lee et al, Decision CTO Study, Circulation 2019;139:1674-1683
  • 17. A.Bufe - EuroCTO Club 2020 Berlin
  • 18. A.Bufe - EuroCTO Club 2020 Berlin n = 19088 Multicenter registry - propensity score - mulivariable analysis Azadani et al., JACC Cardiovac Img 2020 SPECT MPI
  • 19. A.Bufe - EuroCTO Club 2020 Berlin ESC Guidelines 2018
  • 20. A.Bufe - EuroCTO Club 2020 Berlin CTO LCX 1 vessel disease No symtoms
  • 21. A.Bufe - EuroCTO Club 2020 Berlin Rest 30yg 20yg 40yg Dobutamin Stress-MRI
  • 22. A.Bufe - EuroCTO Club 2020 Berlin 6.389 patients Revascularization was associated with a protective effect only in the subset of extensive CMR-related ischaemia Extensive ischaemic burden was related to a higher risc of long term mortality 516/516 matched patients
  • 23. A.Bufe - EuroCTO Club 2020 Berlin LAD-Stenoses RCA-CTO RCA distal NSTEMI anterior wall Hypokinesia anterior and severe Hypokinesia inferior (EF 38%)
  • 24. Claessen et al., EHJ 2012;33:768-775 A.Bufe - EuroCTO Club 2020 Berlin
  • 25. A.Bufe - EuroCTO Club 2020 Berlin epicardial collaterals Stents septal collaterals
  • 26. A.Bufe - EuroCTO Club 2020 Berlin reverse CART Subendocardial Scar inferior MRI for viability
  • 27. A.Bufe - EuroCTO Club 2020 Berlin Complete Revascularization in viable myocardium
  • 28. A.Bufe - EuroCTO Club 2020 Berlin Metha et al., NEJM 2019; 381:1411-1421
  • 29. A.Bufe - EuroCTO Club 2020 Berlin
  • 30. A.Bufe - EuroCTO Club 2020 Berlin Galassi, Mashajekhi et al., J Am Coll Cardiol Intv 2017 n = 839 PCI of CTO in patients with low EF
  • 31. A.Bufe - EuroCTO Club 2020 Berlin n = 72 Galassi, Mashajekhi et al., J Am Coll Cardiol Intv 2017 PCI of CTO in patients with low EF
  • 32. A.Bufe - EuroCTO Club 2020 Berlin Conclusion Galassi et al., EuroCTO Club consensus document, Eurointervention 2019
  • 33. A.Bufe - EuroCTO Club 2020 Berlin Thank you
  • 34. A.Bufe - EuroCTO Club 2020 Berlin Thank you